Abstract
Attempts have been made to use the hypoxanthine-guanine-phospho-ribosyl-transferase-assay as a method for automated screening of agent-induced phenotypic variants of human peripheral lymphocytes reflecting 6-thioguanine resistance and assumed to indicate genotoxic action. Different protocols of the hypoxanthine-guanine-phospho-ribosyl-transferase-system were used in this study in order to investigate whether the system can be a candidate for a short-term test for a rapid and reliable identification of biological systems exposed to agents. The current protocols were based on: 1) fluoresceinated monoclonal antibodies against bromodeoxyuridine-DNA for labelling of 6-thioguanine-resistant human lymphocytes and direct flow-cytometric enumeration of bromodeoxyuridine-positive events and: 2) indirect flow-cytometric enrichment of 6-thioguanine-resistant cells labelled with 3H-thymidine followed by autoradiographic enumeration of positive events. Both the direct and the indirect enumeration method yielded similar results down to the range 10−4 with respect to frequency of variants. For the less time-consuming direct enumeration method the resolution was limited due to non-specific binding of the antibody and false positives. It was, nevertheless, sufficient to score variants induced in vitro with the mutagens EMS, MMC and TT in the same range as e.g. that of cancer patients during and after chemotherapy or radiotherapy, or that of psoriasis patients during and after PUVA (8-methoxypsoralen and long range UV light)-therapy. We conclude that the direct enumeration protocol can be used for a rapid screening of so called outliers, but a more sensitive test, such as the more time-consuming enrichment protocol based on autoradiography, must be used in order to score variants in the range 10−5–10−6
Similar content being viewed by others
Abbreviations
- 3H-TdR:
-
Tritiated thymidine
- BrdU:
-
5-2-bromodeoxyuridine
- DNA:
-
Deoxyribonucleic acid
- EMS:
-
Ethyl-methanesulphonate
- FBS:
-
Fetal bovine serum
- FITC:
-
Fluorescein Isothiocyanate
- G0 :
-
Cell cycle stage
- G1 :
-
Cell cycle stage
- G2 :
-
Cell cycle stage
- HPRT:
-
Hypoxanthine Guanine Phospho Ribosyl Transferase
- LI:
-
Labelling index
- MMC:
-
Mitomycin C
- PBL:
-
Peripheral blood lymphocytes
- PBS:
-
Phosphate buffered saline
- PHA:
-
Phytohemagglutinin
- PI:
-
Propidium iodide
- PUVA:
-
8-Methoxypsoralen and long range UV-light therapy
- RNA:
-
Ribonucleic acid
- RPMI:
-
RPMI-1640 culturing medium
- Se :
-
Early S-stage in the cell-cycle
- Sl :
-
Late S-stage in the cell-cycle
- SCE:
-
Sister chromatid exchange
- TG:
-
6-Thioguanine
- TT:
-
Thiotepa
- UV:
-
Ultraviolet light
- Vf :
-
Variant frequency
References
ALBERTINI, R.J. (1982). “Studies with T-lymphocytes: An approach to Human Mutagenicity Monitoring.” In: Banbury Report, vol. 13, Indicators of Genotoxic exposure (B.A. Bridges, B.E. Butterworth and I.B. Weinstein, eds). Cold Spring Harbor Laboratory. pp 393–412.
ALBERTINI, R.J., SYLWESTER, D.L., and ALLEN E.F. (1982). “The 6-thioguanine-resistant peripheral blood lymphocyte assay for direct mutagenicity testing in humans.” In: Mutagenicity, New Horizons in Genetic Toxicology. (J.A. Heddle, ed). pp. 305–336, Academic Press, New York.
AMNÉUS, H., MATSSON, P., and ZETTERBERG, G. (1982). “Human lymphocytes resistant to 6-thioguanine: Restrictions in the use of a test for somatic mutations arising in vivo studied by flow-cytometric enrichment of resistant cell nuclei.” Mutation Research 106: 163–178.
AMNÉUS, H., SJÖGREN, B., and ZETTERBERG, G. (1984). “Resistance to 6-thioguanine in spontaneously cycling and in mitogen-stimulated human peripheral lymphocytes.” Mutation Research Letters 139: 41–44.
AMNÉUS, H. and ERIKSSON, L. (1986). “The frequency of 6-thioguanine-resistant human peripheral blood lymphocytes as determined by flow-cytometry and by clonal propagation.” Mutation Research 173: 61–66.
DeFAZIO, A., MUSGROVE, E.A., and TATTERSALL, M.H.N. (1988). “Flow cytometric enumeration of drug-resistant tumor cells.” Cancer Research 48: 6037–6043.
DeFAZIO, A., HENEINE, N., MUSGROVE, E.A., and TATTERSALL, M.H. (1989). “Enumeration of 6-thioguanine-resistant tumor cells using flow cytometry and comparison with a microtitration cloning assay.” Mutation Research 216: 57–64.
DOLBEARE, F., GRATZNER, H., PALLAVICINI, M.G., and GRAY, J.W. (1983). “Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.” Proc. Natl. Sci. USA 80: 5573–5577.
EVANS, H.J. and VIJAYALAXMI. (1980). “Storage enhances chromosome damage after exposure of human leukocytes to mitomycin C.” Nature 284: 370–372.
JONES, I.M., ZETTERBERG, G., STROUT, C.L., and CARRANO, A.V. (1985). “Autoradiographic detection of HPRT variants of human lymphocytes resistant to RNA synthesis inhibition.” Mutation Research 149(1): 133–40.
MATSSON, P., AMNÉUS, H., DJUPSJÖBACKA, M., ERIKSSON, B., ERIKSSON, L., FELLNER-FELDEGG, H., and ZETTERBERG, G. (1985). “Direct and indirect flow-cytometric enumeration of 6-thioguanine-resistant human peripheral blood lymphocytes.” Cytometry 6: 648–656.
STRAUSS, G.H. and ALBERTINI, R.J. (1979). “Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo.” Mutation Research 61: 353–379.
STRAUSS, G.H.S. (1982). “Direct mutagenecity testing: The development of a clonal assay to detect and quantitate mutant lymphocytes arising in vivo.” In: Banbury Report, vol. 13, Indicators of Genotoxic Exposure (B.A. Bridges, B.E. Butterworth and I.B. Weinstein, eds). Cold Spring Harbor Laboratory. pp 423–441.
VIJAYALAXMI and EVANS, H.J. (1984). “Induction of 6-thioguanine-resistant mutants and SCEs by 3 chemical mutagens (EMS, ENU and MMC) in cultured human blood lymphocytes.” Mutation Research 129: 283–289.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johannisson, A., Eriksson, B., Amnéus, H. et al. Attempts to use the HPRT-assay as an automated short-term monitor for an acute exposure to mutagens. Cell Biol Toxicol 8, 233–253 (1992). https://doi.org/10.1007/BF00156733
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00156733